Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

The transcription factor TCF-1 initiates the differentiation of TFH cells during acute viral infection

Abstract

Induction of the transcriptional repressor Bcl-6 in CD4+ T cells is critical for the differentiation of follicular helper T cells (TFH cells), which are essential for B cell–mediated immunity. In contrast, the transcription factor Blimp1 (encoded by Prdm1) inhibits TFH differentiation by antagonizing Bcl-6. Here we found that the transcription factor TCF-1 was essential for both the initiation of TFH differentiation and the effector function of differentiated TFH cells during acute viral infection. Mechanistically, TCF-1 bound directly to the Bcl6 promoter and Prdm1 5′ regulatory regions, which promoted Bcl-6 expression but repressed Blimp1 expression. TCF-1-null TFH cells upregulated genes associated with non-TFH cell lineages. Thus, TCF-1 functions as an important hub upstream of the Bcl-6–Blimp1 axis to initiate and secure the differentiation of TFH cells during acute viral infection.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Selective enhancement of TCF-1 expression in virus-specific TFH cells relative to that in TH1 cells after acute infection with LCMV.
Figure 2: TCF-1 is necessary for virus-specific TFH differentiation in response to acute viral infection.
Figure 3: TCF-1 is essential for early but not late differentiation of TFH cells in acute viral infection.
Figure 4: TCF-1 is critical for the effector function of TFH cells.
Figure 5: Distinct transcriptional profiles of TCF-1-deficient TFH cells.
Figure 6: TCF-1 regulates the transcription of Bcl6 and Prdm1 via direct binding.
Figure 7: TCF-1 physically interacts with Bcl-6 protein and enhances Bcl6 transcription.
Figure 8: TCF-1 acts on TFH differentiation upstream of Bcl-6 signaling.

Similar content being viewed by others

Accession codes

Primary accessions

Gene Expression Omnibus

Referenced accessions

Gene Expression Omnibus

References

  1. Plotkin, S.A., Orenstein, W.A. & Offit, P.A. Vaccines 6th edn. (Elsevier, 2013).

  2. Victora, G.D. & Nussenzweig, M.C. Germinal centers. Annu. Rev. Immunol. 30, 429–457 (2012).

    CAS  PubMed  Google Scholar 

  3. Crotty, S. Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 29, 621–663 (2011).

    CAS  PubMed  Google Scholar 

  4. Breitfeld, D. et al. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J. Exp. Med. 192, 1545–1552 (2000).

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Schaerli, P. et al. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J. Exp. Med. 192, 1553–1562 (2000).

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Kim, C.H. et al. Subspecialization of CXCR5+ T cells: B helper activity is focused in a germinal center-localized subset of CXCR5+ T cells. J. Exp. Med. 193, 1373–1381 (2001).

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Ueno, H., Banchereau, J. & Vinuesa, C.G. Pathophysiology of T follicular helper cells in humans and mice. Nat. Immunol. 16, 142–152 (2015).

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Crotty, S. T follicular helper cell differentiation, function, and roles in disease. Immunity 41, 529–542 (2014).

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Johnston, R.J. et al. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 325, 1006–1010 (2009).

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Nurieva, R.I. et al. Bcl6 mediates the development of T follicular helper cells. Science 325, 1001–1005 (2009).

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Yu, D. et al. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity 31, 457–468 (2009).

    CAS  PubMed  Google Scholar 

  12. Choi, Y.S. et al. Bcl6 expressing follicular helper CD4 T cells are fate committed early and have the capacity to form memory. J. Immunol. 190, 4014–4026 (2013).

    CAS  PubMed  Google Scholar 

  13. Xu, H. et al. Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility. Nature 496, 523–527 (2013).

    CAS  PubMed  Google Scholar 

  14. Choi, Y.S., Yang, J.A. & Crotty, S. Dynamic regulation of Bcl6 in follicular helper CD4 T (Tfh) cells. Curr. Opin. Immunol. 25, 366–372 (2013).

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Choi, Y.S., Eto, D., Yang, J.A., Lao, C. & Crotty, S. Cutting edge: STAT1 is required for IL-6-mediated Bcl6 induction for early follicular helper cell differentiation. J. Immunol. 190, 3049–3053 (2013).

    CAS  PubMed  Google Scholar 

  16. Eto, D. et al. IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation. PLoS ONE 6, e17739 (2011).

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Nakayamada, S. et al. Early Th1 cell differentiation is marked by a Tfh cell-like transition. Immunity 35, 919–931 (2011).

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Ise, W. et al. The transcription factor BATF controls the global regulators of class-switch recombination in both B cells and T cells. Nat. Immunol. 12, 536–543 (2011).

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Xue, H.H. & Zhao, D.M. Regulation of mature T cell responses by the Wnt signaling pathway. Ann. NY Acad. Sci. 1247, 16–33 (2012).

    CAS  PubMed  Google Scholar 

  20. Steinke, F.C. et al. TCF-1 and LEF-1 act upstream of Th-POK to promote the CD4+ T cell fate and interact with Runx3 to silence Cd4 in CD8+ T cells. Nat. Immunol. 15, 646–656 (2014).

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Zhou, X. et al. Differentiation and persistence of memory CD8+ T cells depend on T cell factor 1. Immunity 33, 229–240 (2010).

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Zhou, X. & Xue, H.H. Cutting edge: generation of memory precursors and functional memory CD8+ T cells depends on T cell factor-1 and lymphoid enhancer-binding factor-1. J. Immunol. 189, 2722–2726 (2012).

    CAS  PubMed  Google Scholar 

  23. Yu, Q. et al. T cell factor 1 initiates the T helper type 2 fate by inducing the transcription factor GATA-3 and repressing interferon-γ. Nat. Immunol. 10, 992–999 (2009).

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Yu, Q., Sharma, A., Ghosh, A. & Sen, J.M. T cell factor-1 negatively regulates expression of IL-17 family of cytokines and protects mice from experimental autoimmune encephalomyelitis. J. Immunol. 186, 3946–3952 (2011).

    CAS  PubMed  Google Scholar 

  25. Yang, Y., Xu, J., Niu, Y., Bromberg, J.S. & Ding, Y. T-bet and eomesodermin play critical roles in directing T cell differentiation to Th1 versus Th17. J. Immunol. 181, 8700–8710 (2008).

    CAS  PubMed  Google Scholar 

  26. Johnston, R.J., Choi, Y.S., Diamond, J.A., Yang, J.A. & Crotty, S. STAT5 is a potent negative regulator of TFH cell differentiation. J. Exp. Med. 209, 243–250 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Marshall, H.D. et al. Differential expression of Ly6C and T-bet distinguish effector and memory Th1 CD4+ cell properties during viral infection. Immunity 35, 633–646 (2011).

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Hale, J.S. et al. Distinct memory CD4+ T cells with commitment to T follicular helper- and T helper 1-cell lineages are generated after acute viral infection. Immunity 38, 805–817 (2013).

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Verbeek, S. et al. An HMG-box-containing T-cell factor required for thymocyte differentiation. Nature 374, 70–74 (1995).

    CAS  PubMed  Google Scholar 

  30. Ioannidis, V., Beermann, F., Clevers, H. & Held, W. The β-catenin–TCF-1 pathway ensures CD4+CD8+ thymocyte survival. Nat. Immunol. 2, 691–697 (2001).

    CAS  PubMed  Google Scholar 

  31. Liu, X. et al. Transcription factor achaete-scute homologue 2 initiates follicular T-helper-cell development. Nature 507, 513–518 (2014).

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Zhu, J., Yamane, H. & Paul, W.E. Differentiation of effector CD4 T cell populations. Annu. Rev. Immunol. 28, 445–489 (2010).

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Li, L. et al. A far downstream enhancer for murine Bcl11b controls its T-cell specific expression. Blood 122, 902–911 (2013).

    CAS  PubMed  PubMed Central  Google Scholar 

  34. Rosenbauer, F. et al. Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1. Nat. Genet. 38, 27–37 (2006).

    CAS  PubMed  Google Scholar 

  35. Yu, S. et al. The TCF-1 and LEF-1 transcription factors have cooperative and opposing roles in T cell development and malignancy. Immunity 37, 813–826 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Steinke, F.C. & Xue, H.H. From inception to output, Tcf1 and Lef1 safeguard development of T cells and innate immune cells. Immunol. Res. 59, 45–55 (2014).

    CAS  PubMed  Google Scholar 

  37. Satoh, K. et al. Anteriorization of neural fate by inhibitor of β-catenin and T cell factor (ICAT), a negative regulator of Wnt signaling. Proc. Natl. Acad. Sci. USA 101, 8017–8021 (2004).

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Barish, G.D. et al. Bcl-6 and NF-κB cistromes mediate opposing regulation of the innate immune response. Genes Dev. 24, 2760–2765 (2010).

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Hatzi, K. et al. BCL6 orchestrates Tfh cell differentiation via multiple distinct mechanisms. J. Exp. Med. 212, 539–553 (2015).

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Hunt, D., Raivich, G. & Anderson, P.N. Activating transcription factor 3 and the nervous system. Front. Mol. Neurosci. 5, 7 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Regadas, I. et al. Dual role of Tlx3 as modulator of Prrxl1 transcription and phosphorylation. Biochim. Biophys. Acta 1839, 1121–1131 (2014).

    CAS  PubMed  Google Scholar 

  42. Durant, L. et al. Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. Immunity 32, 605–615 (2010).

    CAS  PubMed  PubMed Central  Google Scholar 

  43. Weber, B.N. et al. A critical role for TCF-1 in T-lineage specification and differentiation. Nature 476, 63–68 (2011).

    CAS  PubMed  PubMed Central  Google Scholar 

  44. Rasheed, M.A. et al. Interleukin-21 is a critical cytokine for the generation of virus-specific long-lived plasma cells. J. Virol. 87, 7737–7746 (2013).

    PubMed  PubMed Central  Google Scholar 

  45. Ye, L., Zeng, R., Bai, Y., Roopenian, D.C. & Zhu, X. Efficient mucosal vaccination mediated by the neonatal Fc receptor. Nat. Biotechnol. 29, 158–163 (2011).

    CAS  PubMed  PubMed Central  Google Scholar 

  46. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545–15550 (2005).

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank the Institut Clinique de la Souris (part of the International Knockout Mouse Consortium) for permission to use the mouse with conditional knockout of Tcf7; H.H. Xue (University of Iowa) for Tcf7fl/fl mice and retroviral vectors; R. Ahmed (Emory University) for SMARTA mice and retroviral vectors; CapitalBio for performing microarray experiments and data analysis; and the core facility center of Third Military Medical University for cell sorting. Supported by the National Basic Research Program of China (973 Program, 2013CB531500, to L.Y. and X.Z.), the National Natural Science Foundation of China (31470870 to X.Z., 81471624 to L.Y. and 31000631 to Z.X.), the China1000 Talent Plan Program (L.Y.) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (A.Q.).

Author information

Authors and Affiliations

Authors

Contributions

L.X., Y.C., Z.X., Q.H., Q.B., X.Y., R.H., Y.H., H.W., T.Z., Z.F., A.Q. and J.Y. performed the experiments; Q.B. analyzed the microarray data by GSEA; X.Z. and L.Y. designed the study, analyzed the data and wrote the paper with L.X., Y.C. and Z.X.; and X.Z., L.Y. and Y.W. supervised the study.

Corresponding authors

Correspondence to Xinyuan Zhou, Lilin Ye or Yuzhang Wu.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Integrated supplementary information

Supplementary Figure 1 TCF-1 expression positively correlates with signatures associated with the TFH lineage.

Flow cytometry analysis of TCF-1 expression and other markers related to TFH and TH1 differentiation in SMARTA cells of spleens from SMARTA-chimera mice at day 8 after LCMV infection. The numbers in quadrants indicate the percentage of cells in each. The data are representative of three independent experiments.

Supplementary Figure 2 TCF-1 is essential for TFH differentiation after acute viral infection.

(a) Expression of TCF-1 in CD4+ T cells in spleens from Tcf7−/− and control mice. (b) Flow cytometry of CD4+ T cells in spleens from Tcf7−/− and control mice at day 8 after LCMV infection (left) and quantification of GP66-tetramer-positive cells (right). The numbers above the outlined areas indicate the percentages of tetramer-positive cells (left). (c) Flow cytometry of tetramer-positive CD4+ T cells in spleens from Tcf7−/− and control mice as in b. The numbers above the outlined areas indicate the percentages of TFH cells. (d) Flow cytometry of Foxp3 CD4+ T cells in spleens from Tcf7−/− and control mice (top). The numbers above the outlined areas indicate the percentages of CD44hiCXCR5+ TFH cells. The graphs show the frequency (below, left) and number (below, right) of TFH cells. (e) Flow cytometry of Foxp3+ CD4+ T cells in spleens from Tcf7−/− and control mice (top). The numbers above the outlined areas indicate the percentages of Foxp3+CXCR5+ TFR cells. The graphs show the frequency (below, left) and number (below, right) of TFR cells. (f) Flow cytometry of TFH cells in spleens from Tcf7−/− and control mice as in d. The numbers in quadrants indicate the percentage of cells in each. (g) Quantification of BrdU incorporation (left) and Ki-67 expression (right) in TFH cells from spleens of Tcf7−/− and control mice as in d. (h) Setup of BM chimera experiments. Donor BM cells from Tcf7−/− (CD45.2) and WT (CD45.1) mice were mixed (4:6), and transferred to irradiated WT (CD45.1) mice. After reconstitution, the recipient mice were infected with LCMV. (i) Setup of retrovirus-mediated TCF-1 knockdown in SMARTA cells. Retrovirus-transduced SMARTA cells (CD45.1) were adoptively transferred into WT mice (CD45.2), followed by LCMV infection. (j) Flow cytometry analysis of TCF-1 expression in transduced (GFP+) and non-transduced (GFP) SMARTA cells at day 8 after infection. (k) Flow cytometry of GFP and GFP+ SMARTA cells at day 8 after infection. The numbers adjacent to the outlined areas indicate the percentage of corresponding population. NS, not significant; *P < 0.05 and ***P < 0.001 (unpaired two-tailed t-test). The data are representative of two (cg,j,k) or three (a,b) independent experiments with at least three mice per group (error bars (a,b,d,e,g), SEM).

Source data

Supplementary Figure 3 TCF-1 is required for TFH differentiation after infection with influenza A virus.

(a) Flow cytometry of Foxp3 CD4+ T cells in mediastinal lymph nodes of BM chimeras as in Supplementary Fig. 2 h at day 8 after influenza A virus infection, showing the CXCR5+ TFH population (left) and a summary of the results (right). The numbers adjacent to the outlined areas indicate the percentages of TFH cells. (b) Quantification of MFIs of Bcl-6, ICOS and CXCR5 on TFH cells as in a. *P < 0.05 and **P < 0.01 (paired two-tailed t-test). The data are representative of two independent experiments with four mice per group (error bars, SEM).

Source data

Supplementary Figure 4 Ectopic expression of TCF-1 enhances TFH differentiation.

(a) Flow cytometry analysis of GFP (non-transduced) and GFP+ (overexpressing p33 or p45) SMARTA cells in spleens at day 8 after LCMV infection. The numbers adjacent to the outlined areas indicate the percentages of SLAMloCXCR5+ TFH cells. (b) Summary of TFH frequency and quantification of MFIs of CXCR5, ICOS and Bcl-6 on TFH cells expressing p33 or p45. (c) Experimental setup. Retroviruses overexpressing p33 were introduced into CD45.1+ SMARTA cells, and the cells were transferred into WT recipients (CD45.2), which were subsequently infected with LCMV. At day 8 after infection, transduced GFP+ SMARTA TFH cells were sorted and transferred into day 1-infected recipients, followed by analysis at day 5 after cell transfer. (d) The graphs show a summary of the frequency and number of PNAhiFAShi GC B cells (top) gated on the B220+CD19+ population and CD138hiB220lo plasma cells (below) in spleens at day 5 after cell transfer as in c. *P < 0.05, **P < 0.01 and ***P < 0.001 (unpaired (d) or paired (b) two-tailed t-test).The presented data are representative of two (d) or three (a,b) independent experiments with at least three (a,b) or four (d) mice per group (error bar (d), SEM).

Source data

Supplementary Figure 5 Altered gene expression in TCF-1-deficient TFH cells.

(a) Sorting strategy. (be) WT and Tcf7−/− TFH and TH1 cells were sorted on day 8 after LCMV infection, followed by mRNA extraction and RT-qPCR analysis. NS, not significant; *P < 0.05, **P < 0.01 and ***P < 0.001 (unpaired two-tailed t-test).The data are representative of two (be) independent experiments with two replicates from three mice per group (error bars (be), SEM).

Source data

Supplementary Figure 6 Alignment of the putative TCF-1-binding sites in the Bcl6 promoter and Prdm1 5′ regulatory regions.

The conserved TCF-1-binding motifs “CAAAG” (or “CTTTG” on the reverse strand) are highlighted in red, and their locations relative to the transcriptional starting site (TSS) of Bcl6 or Prdm1 are marked.

Supplementary Figure 7 TCF-1 physically interacts with Bcl-6 protein.

Immunoprecipitation of lysates of activated CD4+ T cells from infected mice at day 8 after infection with a Bcl-6 antibody or control IgG and immunoblot analysis with Bcl-6 and TCF-1 antibodies. The presented data are representative of two independent experiments.

Supplementary Figure 8 ICAT inhibits TFH differentiation.

Flow cytometry analysis of GFP (non-transduced) and GFP+ (overexpressing ICAT) SMARTA cells in spleens at day 3 after LCMV infection. The numbers adjacent to the outlined areas indicate the percentages of Tim3loCXCR5+ TFH cells (left). The graph shows a summary of results (right). ***P < 0.001 (paired two-tailed t-test).The presented data are representative of three independent experiments with at least five mice per group.

Source data

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–8 and Supplementary Tables 1–3 (PDF 2133 kb)

Source data

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, L., Cao, Y., Xie, Z. et al. The transcription factor TCF-1 initiates the differentiation of TFH cells during acute viral infection. Nat Immunol 16, 991–999 (2015). https://doi.org/10.1038/ni.3229

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ni.3229

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing